Why CME couldn’t sell its reg reporting arms

Costs and competition proved fatal for Abide and Nex businesses and trade repositories


In the world of financial technology, mergers and acquisitions (M&A) are simply a way of life. In May 2016, Nex Group was born after Icap sold its broking business to Tullett Prebon. Five months later, Nex (still using the Icap moniker) bought Abide Financial to bolster its suite of regulatory reporting services. Just over two years later, on November 2, 2018, CME Group closed its acquisition of Nex.

But a year after closing the Nex deal, CME couldn’t find any takers for the regulatory

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here